Differences in speech and language abilities between children with 22q11.2 deletion syndrome and children with phenotypic features of 22q11.2 deletion syndrome but without microdeletion

被引:19
|
作者
Rakonjac, Marijana [1 ,2 ]
Cuturilo, Goran [3 ,4 ]
Stevanovic, Milena [5 ]
Jelicic, Ljiljana [1 ,2 ]
Subotic, Misko [1 ,2 ]
Jovanovic, Ida [3 ,4 ]
Drakulic, Danijela [5 ]
机构
[1] Inst Expt Phonet & Speech Pathol, Jovanova 35, Belgrade, Serbia
[2] Life Act Adv Ctr, Jovanova 35, Belgrade, Serbia
[3] Univ Belgrade, Fac Med, Dr Subotica 8, Belgrade 11000, Serbia
[4] Univ Childrens Hosp, Tirsova 10, Belgrade 11000, Serbia
[5] Univ Belgrade, Inst Mol Genet & Genet Engn, Vojvode Stepe 444a, Belgrade 11010, Serbia
关键词
22q11.2DS; Speech and language delay; 5-10 year old children; Congenital heart malformations; CONGENITAL HEART-DISEASE; DE-NOVO MUTATIONS; VELOCARDIOFACIAL SYNDROME; BRAIN-DEVELOPMENT; GENE-EXPRESSION; TRANSPOSITION; IMPAIRMENT; ARTERIES; OUTCOMES; FETUSES;
D O I
10.1016/j.ridd.2016.05.006
中图分类号
G76 [特殊教育];
学科分类号
040109 ;
摘要
Background: 22q11.2DS is the most common microdeletion syndrome in humans, usually associated with speech and language delay (SLD). Approximately 75% of children with 22q11.2 microdeletion have congenital heart malformations (CHM) which after infant open-heart surgery might lead to SLD. Aims: The purpose of this study was to determine whether factors associated with microdeletion contribute to SLD in children with 22q11.2DS. Methods and procedures: We compared speech and language abilities of two groups of school-aged children: those with 22q11.2 microdeletion (E1) and those with the phenotype resembling 22q11.2DS but without the microdeletion (E2). An age-matched group of typically developing children was also tested. Outcomes and results: The obtained results revealed that children from group E1 have lower level of speech and language abilities compared to children from group E2 and control group. Additionally, mild to moderate SLD was detected in children from group E2 compared to children from the control group. Conclusions and implications: The obtained results imply that both CHM after infant open-heart surgery and other factors associated with 22q11.2 microdeletion, contribute to SLD in patients with 22q11.2 microdeletion. Based on this, we could postulate that there is/are some potential candidate gene(s), located in the 22q11.2 region, whose function could be important for speech and language development. (c) 2016 Elsevier Ltd. All rights reserved.
引用
收藏
页码:322 / 329
页数:8
相关论文
共 50 条
  • [31] The Language Profile of Preschool Children With 22q11.2 Deletion Syndrome and the Relationship With Speech Intelligibility
    Everaert, Emma
    Selten, Iris
    Boerma, Tessel
    Houben, Michiel
    Vorstman, Jacob
    de Wilde, Hester
    Derksen, Desiree
    Haverkamp, Sarah
    Wijnen, Frank
    Gerrits, Ellen
    AMERICAN JOURNAL OF SPEECH-LANGUAGE PATHOLOGY, 2023, 32 (01) : 128 - 144
  • [32] Visuomotor abilities and neuropsychological functioning in children and adolescents with 22q11.2 Deletion Syndrome
    Howley, S.
    Prasad, S. E.
    Pender, N. P.
    Murphy, K. C.
    JOURNAL OF INTELLECTUAL DISABILITY RESEARCH, 2007, 51 : 655 - 655
  • [33] Neuropathologic Features in Adults with 22q11.2 Deletion Syndrome
    Kiehl, T. R.
    Chow, E. W. C.
    Mikulis, D. J.
    George, S. R.
    Bassett, A. S.
    CEREBRAL CORTEX, 2009, 19 (01) : 153 - 164
  • [34] Communication issues in 22q11.2 deletion syndrome: Children at risk
    Solot, CB
    Gerdes, M
    Kirschner, RE
    McDonald-McGinn, DM
    Moss, E
    Woodin, M
    Aleman, D
    Zackai, EH
    Wang, P
    GENETICS IN MEDICINE, 2001, 3 (01) : 67 - 71
  • [35] Anomalies of the genitourinary tract in children with 22q11.2 deletion syndrome
    Van Batavia, Jason P.
    Crowley, Terrence B.
    Burrows, Evanette
    Zackai, Elaine H.
    Sanna-Cherchi, Simone
    McDonald-McGinn, Donna M.
    Kolon, Thomas F.
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2019, 179 (03) : 381 - 385
  • [36] Prevalence of hearing loss in children with 22q11.2 deletion syndrome
    Jiramongkolchai, Pawina
    Kumar, Manvinder S.
    Chinnadurai, Sivakumar
    Wootten, Christopher T.
    Goudy, Steven L.
    INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY, 2016, 87 : 130 - 133
  • [37] Movement Disorder Phenotypes in Children With 22q11.2 Deletion Syndrome
    Cunningham, Adam C.
    Fung, Wilson
    Massey, Thomas H.
    Hall, Jeremy
    Owen, Michael J.
    van den Bree, Marianne B. M.
    Peall, Kathryn J.
    MOVEMENT DISORDERS, 2020, 35 (07) : 1272 - 1274
  • [38] Live Vaccine in Children with DiGeorge/22q11.2 Deletion Syndrome
    Miranda, Mariana
    Martins, Andreia Teixeira
    Carvalho, Sara
    Serra-Caetano, Ana
    Esteves, Isabel
    Marques, Jose Goncalo
    ACTA MEDICA PORTUGUESA, 2019, 32 (7-8): : 514 - 519
  • [39] PLAQUETOPATHY ASSOCIATED TO 22Q11.2 DELETION AND NOON SYNDROME IN CHILDREN
    Berrueco Moreno, R.
    Isola, I.
    Gassiot Riu, S.
    Ruiz Llobet, A.
    Catala Temprano, A.
    Diaz Ricart, M.
    Martinez Montseny, A. F.
    Serrano Guimare, M.
    HAEMATOLOGICA, 2019, 104 : 105 - 105
  • [40] Clozapine Use in 22q11.2 Deletion Syndrome
    Colijn, Mark Ainsley
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2024, 44 (02) : 168 - 178